Glooko said yesterday that it inked deals with Dexcom (NSDQ:DXCM) and Insulet (NSDQ:PODD) to supply device data from both companies to its diabetes management platform. Glooko’s platform will now integrate Dexcom’s continuous glucose monitoring systems and Insulet’s OmniPod insulin management systems in a new version of the platform that’s slated for a summer release, the Palo Alto, Calif.-based company […]
The post Diabetes: Glooko adds Dexcom, Insulet to platform appeared first on MassDevice.
from MassDevice http://ift.tt/1eRwhFh
Cap comentari:
Publica un comentari a l'entrada